Put New Aimovig for Migraine Prophylaxis Into Perspective
You'll hear buzz about Aimovig (AIM-oh-vig, erenumab), a new biologic to PREVENT migraines in adults.
It will be the first drug that blocks receptors for calcitonin gene-related peptide (CGRP)...a vasodilator and pain sensitizer that spikes during migraine attacks.
Aimovig may provide one or two fewer migraine days per month versus placebo. This seems similar to first-line oral meds for migraine prophylaxis...such as beta-blockers, topiramate, or valproate.